Advertisement

Picture Kentro Design Corporate and Web Design for Start Ups 650x80px

News > All

Total search results: 4648 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 7 8 9 ... 45 46 47  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
ERS Genomics Ltd.. (2/10/20). "Press Release: ERS Genomics Provides Comment on Affirmation of Key CRISPR-Cas9 Patent Involved in European Opposition Proceedings". Dublin. 2020-02-10
Roche. (2/10/20). "Press Release: Roche Provides Topline Results from Investigator-led Phase II/III Trial with Gantenerumab in Rare Inherited Form of Alzheimer’s Disease". Basel. 2020-02-10
Fluidigm Corporation. (2/10/20). "Press Release: Fluidigm Announces Fourth Quarter and Full Year 2019 Financial Results". South San Francisco, CA. 2020-02-10
Azafaros B.V.. (2/6/20). "Press Release: Azafaros Completes EUR 25 Million Series A Financing to Advance Rare Metabolic Disorders Pipeline". Leiden. 2020-02-06
Lunaphore Technologies S.A.. (2/6/20). "Press Release: Lunaphore Receives CHF 23M Series C Financing, Led by PHC Holdings Corporation". Lausanne. 2020-02-06
Roche. (2/6/20). "Press Release: Roche’s Risdiplam Showed Significant Improvement in Motor Function in People Aged 2-25 with Type 2 or 3 Spinal Muscular Atrophy". Basel. 2020-02-06
PentixaPharm GmbH. (2/6/20). "Press Release: PentixaPharm Secures € 15 Million Series A Financing to Develop CXCR4-Targeted Theranostics". Würzburg. 2020-02-06
Aimmune Therapeutics, Inc.. (2/5/20). "Press Release: Aimmune Therapeutics Announces Additional $200 Million Equity Investment by Nestlé Health Science". Brisbane, CA. 2020-02-05
TreeFrog Therapeutics S.A.S.. (2/5/20). "Press Release: TreeFrog Therapeutics Brings in Senior Profiles to Drive the Advent of High-quality and Affordable Allogenic Cell Therapies". Bordeaux. 2020-02-05
MorphoSys AG. (2/4/20). "Press Release: MorphoSys Initiates Expanded Access Program for Tafasitamab in the U.S.". Planegg. 2020-02-04
Freeline Therapeutics Ltd.. (2/4/20). "Press Release: Freeline Appoints Theresa Heggie as Chief Executive". London. 2020-02-04
BenchSci. (2/4/20). "Press Release: BenchSci Raises $22 Million Series B and Launches New AI-Assisted Reagent Selection Product to Optimize $10.2 Billion in Life Science R&D Spend". Toronto. 2020-02-04
Valneva S.E.. (2/3/20). "Press Release: Valneva Announces New $85 Million Financing Arrangement with Leading US Healthcare Funds Deerfield and OrbiMed". Saint-Herblain. 2020-02-03
Catalent, Inc.. (2/3/20). "Press Release: Catalent, Inc. Announces Pricing of Public Offering of Common Stock". Somers, NJ. 2020-02-03
Stalicla S.A.. (2/3/20). "Press Release: Swiss Biotech Stalicla Announces Closure of USD 8M (CHF 7.7) for Second Tranche of Series A". Geneva. 2020-02-03
Qiagen N.V.. (2/3/20). "Press Release: Qiagen Launches FFPE and Liquid Biopsy PIK3CA Diagnostics in Europe to Enhance Precision Medicine in Advanced Breast Cancer". Germantown, MD & Hilden. 2020-02-03
Business France. (1/31/20). "Press Release: France, Home to Laboratories. This year, 17 French Companies Present Their Expertise at Analytica". 2020-01-31
GeNeuro S.A.. (1/31/20). "Press Release: GeNeuro Announces Successful €17.5 Million Private Placement [Not for United States, Australia, Canada, Japan, South Africa or any other Jurisdiction where Unlawful]". Geneva. 2020-01-31
Bayer AG. (1/31/20). "Press Release: Bayer Welcomes U.S. Environmental Protection Agency’s Reaffirmation that Glyphosate Is Safe to Use, Not Carcinogenic". Whippany, NJ. 2020-01-31
CureVac AG. (1/31/20). "Press Release: CureVac and CEPI Extend Their Cooperation to Develop a Vaccine against Coronavirus nCoV-2019". Tübingen & Boston, MA & Oslo. 2020-01-31
Orion Corporation. (1/31/20). "Press Release: Positive CHMP Opinion for Darolutamide as a New Treatment for Men with Non-metastatic Castration-resistant Prostate Cancer". 2020-01-31
Miltenyi Biotec B.V. & Co. KG. (1/30/20). "Press Release: Miltenyi Biotec Introduces World’s First Operator-free GMP-Compliant Cell Sorting System". Bergisch Gladbach. 2020-01-30
Gilead Sciences, Inc.. (1/30/20). "Press Release: Sandra Horning, MD, Joins Gilead Sciences’ Board of Directors". Foster City, CA. 2020-01-30
Thermo Fisher Scientific Inc.. (1/30/20). "Press Release: Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2019 Results". Waltham, MA. 2020-01-30
PepGen Ltd.. (1/30/20). "Press Release: PepGen Joins Forces with Researchers to Tackle Brain Comorbidity in DMD". 2020-01-30
Quench Bio. (1/27/20). "Press Release: Quench Bio Closes $50M Series A Financing to Advance First-in-Class Medicines Targeting Gasdermin to Treat Severe Inflammatory Diseases". Cambridge, MA. 2020-01-27
Merck KGaA. (1/27/20). "Press Release: Merck Invests in State-Of-The-Art Biotech Development Facility in Switzerland". Corsier-sur-Vevey. 2020-01-27
Santhera Pharmaceuticals Holding AG. (1/24/20). "Press Release: Santhera Appoints New Chief Financial Officer". Pratteln. 2020-01-24
C4Diagnostics S.A.S.. (1/24/20). "Press Release: C4Diagnostics Raises € 2.3 Million in Series A and Brings a US Investor to the Founding Round, to Accelerate the Deployment of Its Infectious Diseases’ Diagnostic Solutions". 2020-01-24
Polyphor Ltd.. (1/23/20). "Press Release: Polyphor Appoints Gökhan Batur as Chief Executive Officer". Allschwil. 2020-01-23
iOnctura B.V.. (1/23/20). "Press Release: iOnctura Raises EUR 15 Million in Series A Financing to Progress Its Pipeline into Clinical Development". Amsterdam. 2020-01-23
Evotec SE. (1/23/20). "Press Release: Evotec and Indivumed Announce Second Joint Drug Discovery Programme". Hamburg. 2020-01-23
Orion Corporation. (1/23/20). "Press Release: Marketing Authorization Granted for Darolutamide in Japan". 2020-01-23
Heidelberg Pharma AG. (1/22/20). "Press Release: Heidelberg Pharma AG Secures Financing Commitment from Its Main Shareholder Dievini". Ladenburg. 2020-01-22
Blueprint Genetics Oy. (1/22/20). "Press Release: Quest Diagnostics Acquires Blueprint Genetics to Broaden Access to Actionable Insights for Genetic and Rare Diseases". 2020-01-22
HepaRegenix GmbH. (1/21/20). "Press Release: HepaRegenix GmbH Secures Series B Financing in Excess of €11 Mio. to Advance First Drug Candidate to the Clinic". Tübingen. 2020-01-21
Bio-Techne Corporation. (1/21/20). "Press Release: Three Industry Leaders Form New Venture to Create Scalable Manufacturing Platforms for Cell and Gene Therapies". Miami, FL. 2020-01-21
Exscientia Ltd.. (1/21/20). "Press Release: Exscientia Appoints Dr. David Hallett as Chief Operating Officer as Company Positions for Further Growth". 2020-01-21
BlueRock Therapeutics. (1/21/20). "Press Release: Ncardia and BlueRock Therapeutics Announce Collaboration Agreement and Licensing of Process Development Technologies for the Manufacture of iPSC-derived Cardiomyocytes". Leiden & Cambridge, MA. 2020-01-21
Novo Holdings A/S. (1/21/20). "Press Release: Novo Seeds Portfolio Company HepaRegeniX GmbH Secures Series B Financing in Excess of EUR 11 Million". Copenhagen. 2020-01-21
CellTool GmbH. (1/20/20). "Press Release: CellTool Appoints Wulf Fischer-Knuppertz as CEO". Tutzing. 2020-01-20
Osteolabs GmbH. (1/20/20). "Press Release: Osteolabs GmbH Successfully Closes First International Commercial Agreements and Starts Contract Research Collaboration with the Health Department of an European Army". Kiel. 2020-01-20
ERS Genomics Ltd.. (1/17/20). "Press Release: ERS Genomics Provides Comment on EPO Technical Board of Appeal Decision Upholding Revocation of Broad Institute CRISPR Patent". Dublin. 2020-01-17
BioNTech SE. (1/16/20). "Press Release: BioNTech to Acquire Neon to Strengthen Global Leadership Position in T Cell Therapies". Mainz & Cambridge, MA. 2020-01-16
Qiagen N.V.. (1/16/20). "Press Release: Qiagen Launches Oncology Molecular Profiling Services in Europe. Qiagen Clinical Insights (QCI) Fully Integrates N-of-One Product into Portfolio". Redwood City, CA & Hilden. 2020-01-16
Sophia Genetics S.A.. (1/15/20). "Press Release: IDT Partners with Sophia Genetics to Increase Access to Clinical-grade Technologies". Coralville, IA. 2020-01-15
High-Tech Gründerfonds Management GmbH. (1/15/20). "Press Release: HTGF Portfolio Company. Cunesoft Joins Forces with Phlexglobal". 2020-01-15
High-Tech Gründerfonds Management GmbH. (1/15/20). "Press Release: Biograil Secures Seed Funding for Oral Delivery Device with Potential to Transform Market for Injectables". 2020-01-15
Curetis N.V.. (1/14/20). "Press Release: Curetis Launches Unyvero LRT Panel for BAL Specimens in the U.S.". Amsterdam, Holzgerlingen & San Diego, CA. 2020-01-14
Vivoryon Therapeutics AG. (1/14/20). "Press Release: Vivoryon Therapeutics and Nordic Bioscience Enter Research and Development Collaboration". Halle (Saale) & Herlev. 2020-01-14
ProBioGen AG. (1/14/20). "Press Release: ProBioGen and Lava Therapeutics Sign Cell Line Development and GMP Manufacturing Agreement for Novel Bispecific Molecule". Berlin & Utrecht. 2020-01-14
Temedica GmbH. (1/14/20). "Press Release: Temedica Raises $19 Million Series B Funding". Munich. 2020-01-14
Valneva S.E.. (1/14/20). "Press Release: US DoD Exercises Option on Ixiaro Supply Contract Bringing Total Value to $70 Million". Saint-Herblain. 2020-01-14
MorphoSys AG. (1/13/20). "Press Release: MorphoSys and Incyte Sign Global Collaboration and License Agreement for Tafasitamab". Planegg & Wilmington, DE. 2020-01-13
Roche. (1/13/20). "Press Release: Roche and Illumina Partner to Broaden Patient Access to Genomic Testing". Basel. 2020-01-13
Waters Corporation. (1/13/20). "Press Release: Waters to Acquire Andrew Alliance". Milford, MA. 2020-01-13
ERS Genomics Ltd.. (1/13/20). "Press Release: ERS Genomics Licenses CRISPR Gene Editing Technology to Daiichi Sankyo to Support Internal Research and Development". Dublin. 2020-01-13
BioNTech SE. (1/13/20). "Press Release: BioNTech Appoints Ryan Richardson as Chief Strategy Officer to Support its Continued Global Expansion". Mainz. 2020-01-13
Qiagen N.V.. (1/13/20). "Press Release: Qiagen Builds on Global Collaboration with Amgen for Companion Diagnostic Development in Non-small Cell Lung Cancer". Hilden & Germantown, MD. 2020-01-13
NBE Therapeutics AG. (1/10/20). "Press Release: NBE-Therapeutics Closes a USD 22M Series C Financing Round". Basel. 2020-01-10
Proteomedix AG. (1/10/20). "Press Release: Proteomedix Appoints Helge Lubenow as New CEO". Zürich-Schlieren. 2020-01-10
Qiagen N.V.. (1/10/20). "Press Release: Qiagen Celebrates Surpassing 2,500 Cumulative Placements of QIAsymphony. Milestone Instrument Placed with Cenata GmbH in Germany". Hilden & Germantown, MD. 2020-01-10
Bayer AG. (1/10/20). "Press Release: Bayer and Azitra Partner to Harness the Human Skin Microbiome as a Source for New Nnatural Skin Care Products for Sensitive and Eczema-prone Skin". Leverkusen & Farmington, CT. 2020-01-10
Evotec SE. (1/9/20). "Press Release: Bayer and Evotec Form New Strategic Alliance Focusing on Polycystic Ovary Syndrome". Hamburg & Berlin. 2020-01-09
Alderaan Biotechnology S.A.S.. (1/9/20). "Press Release: Alderaan Biotechnology Raises €18.5m in Series A from Advent France Biotechnology (AFB) and Medicxi". Paris. 2020-01-09
Novadiscovery S.A.S.. (1/9/20). "Press Release: Novadiscovery Raises Series A Financing to Scale Its in silico Clinical Trial Platform – Debiopharm Leads the Round with EUR 5 Million". 2020-01-09
Boehringer Ingelheim. (1/9/20). "Press Release: Boehringer Ingelheim Partners with Enleofen to Develop First-in-Class Anti-IL-11 Therapies for a Range of Fibrotic Diseases". Ingelheim & Singapore. 2020-01-09
Selexis S.A.. (1/9/20). "Press Release: Selexis Promotes Dr. Yemi Onakunle to Chief Business Officer". Geneva. 2020-01-09
Emergex Vaccines Holding Ltd.. (1/9/20). "Press Release: Emergex Raises more than US$11 Million in a Series A Round to Progress Its Pipeline of Set-point Vaccines for Infectious Diseases". Abingdon. 2020-01-09
Bayer AG. (1/9/20). "Press Release: Bayer and Exscientia Collaborate to Leverage the Potential of Artificial Intelligence in Cardiovascular and Oncology Drug Discovery". Berlin. 2020-01-09
Valneva S.E.. (1/9/20). "Press Release: Valneva Expands its Commercial Operations with the Opening of its French Commercial Office". Saint-Herblain. 2020-01-09
Wellington Partners. (1/8/20). "Press Release: Karl Naegler Joins Wellington Partners as Managing Partner". Munich. 2020-01-08
Esteve Pharmaceuticals, S.A.. (1/8/20). "Press Release: Esteve Acquires German Proprietary, Specialty, Hospital-focused Company Riemser and Expands Its Presence in Europe". 2020-01-08
NorthSea Therapeutics B.V.. (1/8/20). "Press Release: NorthSea Therapeutics Announces US $40 Million Series B Financing to Complete Phase IIb ICONA Study in NASH and to Advance Two Additional SEFAs into the Clinic". Naarden. 2020-01-08
BC Platforms. (1/8/20). "Press Release: BC Platforms Partners with Dante Labs to Build Europe's Largest Next Generation Sequencing Laboratory for Private and Public Customers". Zürich & Boston, MA. 2020-01-08
ProBioGen AG. (1/8/20). "Press Release: ProBioGen Inks Next Commercial GlymaxX License with Roche. ADCC-enhancement for Innovative Cancer Therapy". Berlin. 2020-01-08
Eyevensys S.A.S.. (1/8/20). "Press Release: Eyevensys Closes $30M Series B Financing". Paris & Fort Worth, TX. 2020-01-08
Ori Biotech Ltd.. (1/8/20). "Press Release: Ori Biotech Announces a $9.4m Seed Round to Advance Innovation in Cell and Gene Therapy Manufacturing". London & Philadelphia, PA. 2020-01-08
Phlexglobal Ltd.. (1/8/20). "Press Release: Phlexglobal Acquires Cunesoft". Amersham & Malvern, PA. 2020-01-08
Immunic, Inc.. (1/8/20). "Press Release: Immunic Exercises its Option for the Exclusive Worldwide License to IMU-856 from Daiichi Sankyo Co., Ltd.". New York, NY. 2020-01-08
PhoreMost Ltd.. (1/7/20). "Press Release: PhoreMost and Boehringer Ingelheim Enter Multi-project Drug Discovery Collaboration". Cambridge. 2020-01-07
Velabs Therapeutics GmbH. (1/7/20). "Press Release: Velabs Therapeutics Receives Exclusive Licence from Alytas Therapeutics for the Development of Therapeutic Antibodies as Senolytics". Heidelberg & Jena. 2020-01-07
genOway S.A.. (1/7/20). "Press Release: genOway and Merck Strengthen CRISPR/Cas9 Strategic Alliance by Extending Their Partnership to All Animal Cell Models". Lyon. 2020-01-07
CureVac AG. (1/7/20). "Press Release: CureVac Announces Positive Results in Low Dose – 1 µg – Rabies Vaccine Clinical Phase 1 Study". Tübingen & Boston, MA. 2020-01-07
VectivBio AG. (1/7/20). "Press Release: VectivBio Launches with $35M Financing to Bring Best-in-Disease Medicines to Patients with Serious Rare Diseases". Basel. 2020-01-07
Evotec SE. (1/7/20). "Press Release: Evotec and Bristol-Myers Squibb Expand iPSC Collaboration". Hamburg. 2020-01-07
ERS Genomics Ltd.. (1/7/20). "Press Release: ERS Genomics Announces Agreement with New England Biolabs to Commercialize CRISPR Gene Editing Tools and Reagents". Dublin & Ipswich, MA. 2020-01-07
Galecto Biotech AB. (1/7/20). "Press Release: Galecto and PharmAkea Merge to Create Strong Clinical-stage Company Developing First-in-Class Therapeutics in Fibrosis and Cancer". San Diego, CA & Copenhagen. 2020-01-07
Bayer AG. (1/7/20). "Press Release: Bayer Exercises Right to Enter into Follow-on Research and Collaboration Option Agreement with Atomwise. Companies to Continue Crop Protection Development Programs". Monheim & San Francisco, CA. 2020-01-07
Novartis AG. (1/6/20). "Press Release: Novartis Successfully Completes Acquisition of The Medicines Company, Adding a Potentially First-in-Class, Investigational Cholesterol-lowering Therapy Inclisiran". Basel. 2020-01-06
Novartis AG. (1/6/20). "Press Release: Novartis Completes Tender Offer for All Outstanding Shares of The Medicines Company". Basel. 2020-01-06
MorphoSys AG. (12/30/19). "Press Release: MorphoSys Announces Submission of Biologics License Application for Tafasitamab in r/r DLBCL to the FDA". Planegg. 2019-12-30
Codexis, Inc.. (12/23/19). "Press Release: Codexis Announces License Agreement with Roche for Enzyme Used in Next Generation Sequencing". Redwood City, CA. 2019-12-23
Nabriva Therapeutics plc. (12/20/19). "Press Release: Nabriva Therapeutics Announces $20 Million Registered Direct Offering". Dublin & King of Prussia, PA. 2019-12-20
Nabriva Therapeutics plc. (12/20/19). "Press Release: Nabriva Therapeutics Resubmits New Drug Application for Intravenous Contepo (fosfomycin) for Injection". Dublin. 2019-12-20
Valneva S.E.. (12/20/19). "Press Release: Valneva Completes Delisting from the Vienna Stock Exchange". Saint-Herblain. 2019-12-20
Genmab A/S. (12/19/19). "Press Release: Genmab and CureVac Enter Strategic Partnership to Develop mRNA-based Antibody Therapeutics". Copenhagen & Tübingen. 2019-12-19
Merck KGaA. (12/19/19). "Press Release: Merck Licenses Foundational CRISPR Integration Technology to Promega". Darmstadt. 2019-12-19
Kinnate Biopharma, Inc.. (12/19/19). "Press Release: Kinnate Biopharma Closes $74.5M Series B Financing". San Diego, CA. 2019-12-19
Genomill Health. (12/18/19). "Press Release: Genomill Health Closes Investment Round to Expand Beta-testing with Liquid Biopsy Players". Turku. 2019-12-18
next pagenext page 1 2 3 ... 7 8 9 ... 45 46 47  next pagenext page



Advertisement

Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture EBD Group BIO-Europe Spring 2021 Digital 650x80

» top